Stocks
Health Care
vrca
Verrica Pharmaceuticals
NASDAQ: VRCA
+2.29 (+34.13%)
9
USD
At close at Nov 28, 21:42 UTC
Overview
Loading chart...
Key Stats
Market Cap
85.96M
Dividend Yield
0.00%
P/E Ratio
-3.30
EPS
-14.80
Revenue
7.57M
Avg. Volume
1.16M
Recently from Cashu
No Cashu articles
Verrica Pharmaceuticals currently has no Cashu-related articles
About
What does VRCA do?
Verrica Pharmaceuticals, headquartered in West Chester, Pennsylvania, develops treatments for skin diseases and went public in June 2018. Its pipeline includes YCANTH, VP-315, and VP-103 for various skin conditions.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.